NCT07305649Not yet recruiting
The Effectiveness of an Innovative Inhalation Training Device in Improving Medication Accuracy, Dyspnea, and Quality of Life in Elderly Patients With Chronic Obstructive Pulmonary Disease
Source: ClinicalTrials.gov · Last updated 26 Dec 2025
Brief summary (registry, in English)
This study aims to evaluate the effectiveness of an innovative inhaler training device, "Golden Rhino" (pMDI Practice Tool), in improving inhalation technique accuracy, dyspnea severity, and quality of life among elderly patients with chronic obstructive pulmonary disease (COPD). The device integrates a weighted valve and musical cues to guide patients in synchronizing their breath with proper pMDI inhalation technique. Participants will be randomly assigned to either standard nursing guidance or nursing guidance plus device-based training. Outcome measures include pMDI usage accuracy, dyspnea severity, and EQ-5D quality of life scores at baseline and follow-up.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 82 (estimated)
- First submitted
- 3 Dec 2025
- Start date
- 19 Dec 2025
- Primary completion date
- 31 Dec 2026
- Lead sponsor
- Taipei Veterans General Hospital, Taiwan
- Diseases
- COPD
- NCT number
- NCT07305649
What you commit to
- Study type: Interventional
- Planned participants: 82
- From 19 Dec 2025 to the primary completion date, 31 Dec 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Concurrent enrollment in another interventional clinical trial
Other illness
- Diagnosis of severe cognitive impairment (e.g., dementia) that may interfere with participation
- Severe visual or hearing impairment that may limit the ability to follow inhaler training instructions
- Other diagnosed pulmonary diseases (e.g., lung cancer, pulmonary fibrosis) that may affect the assessment of COPD outcomes
Other
- Acute COPD exacerbation requiring hospitalization within the past 30 days
Who the study is looking for
- Age ≥ 65 years old
- Clinically diagnosed with Chronic Obstructive Pulmonary Disease (COPD) according to GOLD criteria
- Currently using pressurized Metered Dose Inhaler (pMDI) medications
- Ability to communicate and understand instructions in Mandarin or Taiwanese
- Willing to participate and provide informed consent
Age in the registry: 65 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Taipei Veterans General Hospital Coordinator of this site? Confirm its status | Taipei | Taiwan | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.